Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 53.33% · OPTIONAL
· Services-Medical Laboratories
RESEARCH SNAPSHOTSERA PROGNOSTICS, INC.'s latest supported as-filed period reports revenue of $30,000, 76.5% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 53.33% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -21036.67% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 76.47% · CORE
Level · gp.fundamentals.gross_margin
Raw value -66.67% · CORE
Level · gp.fundamentals.operating_margin
Raw value -33346.67% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 11643.33% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 3 independently calculated changes: Revenue increased 76.5%; Operating margin moved 2147686 bp higher; Operating income decreased 7.3%.
3 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 76.5%; Operating margin moved 2147686 bp higher; Operating income decreased 7.3%.
3 evidence-backed componentsThis cluster groups 2 independently calculated changes: Cash & equivalents decreased 12.3%; Operating cash flow decreased 15.3%.
2 evidence-backed componentsOperating margin changed +2147686 basis points from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
SERA · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001891299-26-000012SEC ↗4Sep 2, 2026Period Aug 31, 20260001979974-26-000010SEC ↗4Sep 1, 2026Period Aug 31, 20260001883387-26-000005SEC ↗8-KAug 19, 2026Period Aug 14, 20260001193125-26-357112SEC ↗10-QAug 12, 2026Period Jun 30, 20260001193125-26-346862SEC ↗8-KAug 12, 2026Period Aug 12, 20260001193125-26-346846SEC ↗4Jul 14, 2026Period Jul 10, 20260001871555-26-000002SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Sep 8, 2026Filed Sep 9, 2026 | Lindgardt ZhenyaChief Executive Officer | Open Market SaleDirect | 20,139 | $2 | $40,278 | Form 4 ↗ |
| Aug 31, 2026Filed Sep 1, 2026 | Gleason ScottChief Financial Officer | Grant Or AwardDirect | 117,924 | $0 | $0 | Form 4 ↗ |
| Aug 31, 2026Filed Sep 1, 2026 | Gleason ScottChief Financial Officer | Grant Or AwardDirect | 169,624 | $0 | $0 | Form 4 ↗ |
| Jul 10, 2026Filed Jul 14, 2026 | Phillips JoshuaDirector | Grant Or AwardDirect | 22,426 | $0 | $0 | Form 4 ↗ |
| Jul 10, 2026Filed Jul 14, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Level · gp.fundamentals.sbc_revenue_ratio
Raw value 2743.33% · OPTIONAL
Capex / revenue changed -159961 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Revenue changed +76.5% from the comparable as-filed period.
Capital expenditure changed -94.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow changed -15.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Trade receivables changed -41.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating income changed -7.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001588389-26-000002| Phillips JoshuaDirector |
| Grant Or AwardDirect |
| 3,477 |
| $0 |
| $0 |
| Form 4 ↗ |
| Jul 10, 2026Filed Jul 14, 2026 | Phillips JoshuaDirector | Grant Or AwardDirect | 2,260 | $0 | $0 | Form 4 ↗ |
| Jul 10, 2026Filed Jul 14, 2026 | Phillips JoshuaDirector | Grant Or AwardDirect | 34,494 | $0 | $0 | Form 4 ↗ |